Emerging Opportunities in Cancer Nucleic Acid Testing
NEW YORK, Feb. 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Emerging Opportunities in Cancer Nucleic Acid Testinghttp://www.reportlinker.com/p0773576/Emerging-Opportunities-in-Cancer-Nucleic-Acid-Testing.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory
The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing NAT technologies and products for cancer testing.
Contains 45 pages
Table of Contents2. Major Cancer Types
* Prostate
* Lung
* Colon and Rectum
* Breast
* Skin
* Uterine
* Leukemia
* Oral
3. Oncogenes
O Abl/abl-bcr
O AIB1
O BCL-2
O BRCA1
O CD44
O C-fos
O C-myb
O C-myc
O CYP17
O Erb-B
O HPC1
O N-myc
O P40
O P51
O P53
O PIK3CA
O PTI-1
O Ras
O Reg
O Sis
O Src
Tables: Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing
Cancer Molecular Diagnostic Tests
To order this report:: Emerging Opportunities in Cancer Nucleic Acid TestingMore
Market Research ReportCheck our
Industry Analysis and InsightsNicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article